In brief
This proposal investigates how adults with COVID-19 might develop new-onset diabetes, looking at both genetic factors (via GWAS) and social determinants. Using data from the All of Us database, it aims to find who is most at risk, inform prevention strategies, and train nurse scientists in advanced research methods.
What this article is about
Quick Answer
This proposal investigates how adults with COVID-19 might develop new-onset diabetes, looking at both genetic factors (via GWAS) and social determinants. Using data from the All of Us database, it aims to find who is most at risk, inform prevention strategies, and train nurse scientists in advanced research methods.
Student takeaways
Key Takeaways
- The study aims to determine the true prevalence of new-onset diabetes in individuals post-COVID-19 infection.
- It will investigate how individual genetic factors (via GWAS) influence the development of new-onset diabetes after COVID-19.
- The research will explore how external social determinants of health impact this risk.
- Findings are expected to identify populations at higher risk for developing new-onset diabetes post-COVID-19.
- The study's results could inform prevention strategies and early intervention programs.
Student summary
Why This Research Matters
This research proposal, titled 'An epidemiological study to investigate the multifactoral nature of diabetes risk among adults with COVID-19 with a genetic and social determinants of health lens,' outlines an important investigation into how individuals who have had COVID-19 might develop new-onset diabetes. The primary focus is on understanding not just whether this happens, but also why it happens by looking at both individual factors (like genetics) and external factors (like social conditions). As a nursing student, you should understand the core problem: post-COVID infections are increasingly common, and emerging evidence suggests that some individuals might develop new-onset diabetes following these infections. This study aims to quantify this risk and identify who is most susceptible.
The research will address two main questions: 1. What is the actual prevalence of new-onset diabetes in adults after they have had COVID-19? (This means how common it is). 2. How do various individual factors (such as specific genetic markers identified through genome-wide association studies) and external social determinants of health (like socioeconomic status, access to healthcare, or environmental exposures) influence the development of this new-onset diabetes?
To answer these questions, the study proposes a multi-faceted approach: * **Systematic Review and Meta-Analysis:** This involves collecting and analyzing existing published research on new-onset diabetes post-COVID-19. By synthesizing data from multiple studies, researchers can get a more robust estimate of its prevalence. * **Utilization of the All of Us Database:** The study will leverage this large real-world data platform. It contains extensive biomedical and health-related information collected prospectively (meaning it's gathered over time as events occur) from a diverse group of participants in the United States. This database is crucial because it allows researchers to investigate individual factors like genetic predispositions by linking survey responses with biological samples. * **Genome-Wide Association Studies (GWAS):** These studies will be conducted using data from All of Us to identify specific genetic variations that might increase an individual's risk of developing new-onset diabetes after a COVID-19 infection. GWAS involves scanning the entire genome for markers associated with a particular trait or disease. * **Investigation of Individual and External Factors:** Beyond genetics, the study will explore how other personal characteristics (e.g., age, sex, pre-existing conditions) and broader social determinants of health (e.g., income level, education, neighborhood environment) contribute to this risk. This holistic approach is vital for understanding complex health outcomes.
The ultimate goals are significant: * **Identify Populations at Risk:** The findings will help pinpoint specific groups who are more vulnerable to developing new-onset diabetes after COVID-19. This could include people with certain genetic profiles or those living in particular social circumstances. * **Assess Potential Shifts in Disease Burden:** Understanding the scale of this emerging health issue is crucial for public health planning and resource allocation. * **Inform Prevention and Early Intervention Strategies:** By knowing who is at risk and why, healthcare providers can develop targeted screening programs and preventive measures. This could lead to earlier detection and better management of diabetes in post-COVID-19 patients.
The study emphasizes the importance of training nurse scientists like Jordan Keels (the principal investigator) in advanced data analysis techniques and interdisciplinary research methods. The project is supported by Boston College Connell School of Nursing, which provides a strong institutional environment with resources for this type of complex research.
As nursing students, you should appraise several aspects: * **The Rationale:** Is the problem clearly defined? Does it highlight an important gap in current knowledge? * **Methodology:** Are the proposed methods (systematic review, meta-analysis, use of All of Us data, GWAS) appropriate and robust for answering the research questions? * **Data Source:** The All of Us database is a powerful tool, but it's essential to consider its representativeness and potential biases. * **Training Component:** How does this project contribute to developing future nurse scientists capable of conducting rigorous health informatics research?
When considering source and rights: This record comes from NIH RePORTER, which provides public metadata for funded projects. The abstract is the primary source of information about the study's aims and methods. While it doesn't contain raw data or detailed findings (as this is a proposal), it clearly outlines the planned research.
As future nurses, you would reason from this evidence by understanding that new-onset diabetes post-COVID-19 is an emerging concern with multifactorial causes. The study's focus on both genetic and social determinants underscores the complexity of health outcomes. If findings confirm a significant risk, it will be crucial for nursing practice to incorporate screening protocols for diabetes in post-recovery care pathways, particularly for identified high-risk populations. This research exemplifies how nursing science can contribute to understanding complex public health challenges through innovative use of data and interdisciplinary collaboration.
Source abstract
Study Overview
This proposal seeks to enhance our understanding of new-onset diabetes in individuals following infection. This study will investigate 1) the prevalence of new-onset diabetes post-infection 2) how individual and external factors influence the development of new-onset diabetes. Study findings will identify populations at risk, assess potential shifts in disease burden, and inform prevention and early intervention strategies. A systematic review and meta-analysis will be conducted to determine the true prevalence of new-onset diabetes in individuals post-infection. In addition, the study will utilize the All of Us database, a real-world data platform that encompasses one of the largest, multifaceted collections of biomedical data. The proposed study will use prospective survey data from the All of Us database to investigate individual and external factors related to new-onset diabetes. To inform risk of new-onset diabetes related to individual factors, genome wide association studies will be conducted by using data collected from the All of Us database. The training plan for this fellowship will provide opportunities to develop and apply knowledge on how individual and external factors influence health outcomes and disease prevalence, as well as advanced data analysis techniques. In addition, the fellow will partake in professional development activities aimed at nurturing a well-rounded nurse scientist. Such training opportunities include structured and experiential learning activities to develop substantive and methodological knowledge. Interdisciplinary team-based research experiences and mentorship will complement formal and experiential learning opportunities. A strong mentoring team has been assembled with experts in endocrinology and diabetes, health informatics and data science, and statistical methodology. The proposed study and study sponsors are supported by the institutional environment of Boston College Connell School of Nursing which has significant resources to support the proposed project. The mentoring team and institutional environment are well-suited for the successful completion of the proposed project and training plan for this fellowship. This study addresses the NIH priorities through leveraging real-world data to address chronic disease development (i.e., diabetes) with a replicable, methodologically rigorous approach, using clearly measurable health outcomes (i.e., new-onset diabetes). This strongly aligns with NIH priorities on real-world data platforms, reproducible science, training the future biomedical workforce, chronic disease research, and solution-oriented approaches to improving population health. Findings will identify populations at risk and guide the development of targeted interventions, enable earlier detection and prevention, while optimizing public health strategies to address the broader burden of the chronic disease crisis.
Evidence appraisal
Main Findings
- The study aims to determine the true prevalence of new-onset diabetes in individuals post-COVID-19 infection.
- It will investigate how individual genetic factors (via GWAS) influence the development of new-onset diabetes after COVID-19.
- The research will explore how external social determinants of health impact this risk.
- Findings are expected to identify populations at higher risk for developing new-onset diabetes post-COVID-19.
- The study's results could inform prevention strategies and early intervention programs.
Practice transfer
Clinical Relevance
- Identification of high-risk individuals (genetically predisposed or socially disadvantaged) allows for targeted screening and monitoring in clinical settings, particularly among COVID-19 survivors.
- Findings can guide the development of personalized preventive care plans, potentially incorporating lifestyle modifications or pharmacological interventions tailored to individual risk profiles.
- The research may lead to earlier detection of new-onset diabetes post-COVID-19, enabling timely intervention to prevent complications and improve long-term health outcomes for patients.
- Insights into social determinants can inform public health initiatives aimed at reducing disparities in diabetes incidence among COVID-19 survivors by addressing modifiable environmental factors.
- The study's emphasis on real-world data (All of Us) highlights the potential for leveraging large-scale databases to rapidly generate actionable clinical insights during emerging health crises.
Faculty notes
Educational Relevance
This NIH-funded research proposal by Jordan Keels at Boston College Connell School of Nursing outlines a comprehensive epidemiological study designed to investigate the multifactorial nature of new-onset diabetes risk among adults following COVID-19 infection. The project's central aim is to elucidate how both individual (genetic) and external (social determinants of health) factors contribute to this emerging post-infectious complication.
The research will address two primary objectives: first, to determine the true prevalence of new-onset diabetes in individuals who have experienced COVID-19; second, to identify specific individual genetic markers through genome-wide association studies (GWAS), and external social determinants that influence the development of this condition. The proposed methodology is robust and multi-pronged:
* **Systematic Review & Meta-analysis:** This foundational step will synthesize existing literature on new-onset diabetes post-COVID-19 to establish a baseline understanding of its prevalence across different populations. * **All of Us Database Utilization:** The study leverages the All of Us Research Program, a large-scale real-world data platform. This database is invaluable for investigating individual factors like genetic predispositions by linking prospective survey data with biological samples and health records from a diverse US population. * **Genome-Wide Association Studies (GWAS):** These will be conducted using data from All of Us to identify specific genetic variants associated with an increased risk of new-onset diabetes following COVID-19. This is critical for understanding the heritable component of this post-infectious outcome. * **Investigation of Social Determinants:** The study design explicitly incorporates analysis of external factors such as socioeconomic status, access to healthcare, education levels, and environmental exposures, recognizing their significant impact on health outcomes.
The project's significance lies in its potential to identify high-risk populations for targeted interventions. By understanding the interplay between genetic susceptibility and social context, researchers can inform prevention strategies that go beyond individual-level care to address broader public health needs. The findings are expected to guide earlier detection efforts, optimize resource allocation, and ultimately reduce the burden of this new chronic disease manifestation.
The proposal highlights a strong training component for Jordan Keels as a nurse scientist fellow. This includes developing expertise in advanced data analysis techniques (including GWAS), understanding how individual and external factors influence health outcomes, and gaining experience through interdisciplinary team-based research experiences with mentors from endocrinology/diabetes, health informatics/data science, and statistical methodology. The institutional support at Boston College Connell School of Nursing is noted as crucial for project completion.
From an educational perspective, this proposal serves as a valuable case study in several areas: * **Research Design:** It demonstrates the integration of multiple research methods (systematic review, meta-analysis, GWAS) to address complex health questions. * **Nursing Science and Informatics:** The project exemplifies how nursing science can contribute to understanding chronic disease development through innovative use of large-scale real-world data platforms like All of Us. * **Interdisciplinary Collaboration:** It underscores the importance of collaboration between nurses, endocrinologists, data scientists, and statisticians in modern health research. * **Training Future Nurse Scientists:** The fellowship structure provides a clear model for developing advanced methodological skills and substantive knowledge in nursing researchers.
Faculty should consider this proposal as an example of how to frame a compelling research question around emerging public health issues (post-COVID-19 complications) using rigorous, data-driven approaches. It also illustrates the alignment with NIH priorities such as leveraging real-world data for chronic disease research and training the future biomedical workforce.
Critical appraisal
Limitations
- As a proposal, it outlines intended research but has not yet yielded empirical findings or results.
- The abstract does not specify sample size details for the proposed GWAS or prospective survey analysis from All of Us data; these are crucial for assessing statistical power and generalizability once the study is implemented.
- While the All of Us database is large, its representativeness across all demographic groups in the US population needs to be critically evaluated by researchers when interpreting results. Potential selection biases inherent in any large observational dataset could also affect findings.
Classroom use
Discussion Questions
- What specific genetic markers are hypothesized or expected to emerge from the GWAS component as significant predictors of new-onset diabetes post-COVID-19?
- How will the study operationally define and measure 'social determinants of health' (e.g., income, education, neighborhood environment) in relation to this risk? What specific variables will be analyzed?
- What are the anticipated challenges in linking COVID-19 infection data with subsequent diabetes diagnoses within the All of Us database?
- How might findings from a US-based study like this translate or need adaptation for application in other global contexts with different healthcare systems and social structures?
- Beyond identifying risk, what specific prevention strategies (e.g., lifestyle interventions, pharmacological screening) are envisioned based on these multifactorial insights?
- What ethical considerations arise when using large-scale genomic data from a database like All of Us to study post-infectious conditions such as new-onset diabetes?
- How will the results be disseminated to healthcare providers and public health officials in a way that effectively translates research into practice?
- Could this research model (integrating systematic review, meta-analysis, GWAS, and social determinant analysis) be applied to investigate other emerging post-infectious syndromes beyond new-onset diabetes?
- What are the potential long-term implications for healthcare resource allocation if significant numbers of COVID-19 survivors develop new-onset diabetes?
- How does this study contribute to our understanding of the broader concept of 'long COVID' and its associated health complications?
Search-ready answers
Frequently asked questions
What are the main objectives of this epidemiological study on diabetes risk?
The study aims to investigate two primary aspects: first, determining the prevalence of new-onset diabetes post-infection (specifically COVID-19), and second, understanding how individual factors (like genetics) and external factors influence the development of new-onset diabetes.
Which database will be used for this research?
The study will utilize data from the All of Us database, described as a real-world data platform encompassing one of the largest, multifaceted collections of biomedical data.
What specific types of analyses are planned in this study?
The proposed study includes two main analytical approaches: 1) A systematic review and meta-analysis to determine the true prevalence of new-onset diabetes post-infection. 2) Genome-wide association studies (GWAS) using data from the All of Us database to investigate individual factors related to new-onset diabetes.
What is the primary focus of this research in terms of health outcomes?
The study focuses on identifying populations at risk for new-onset diabetes following COVID-19 infection, assessing potential shifts in disease burden, and informing prevention and early intervention strategies.
What is the training plan associated with this fellowship?
The training plan aims to develop knowledge on how individual and external factors influence health outcomes and disease prevalence, as well as advanced data analysis techniques. It includes professional development activities for a well-rounded nurse scientist, structured learning, experiential learning, interdisciplinary team-based research experiences, and mentorship.
Who are the key experts involved in mentoring this fellow?
A strong mentoring team has been assembled with experts in endocrinology and diabetes, health informatics and data science, and statistical methodology.
What is the institutional support for this project?
The proposed study and fellow are supported by Boston College Connell School of Nursing, which has significant resources to support the project. The mentoring team and institutional environment are considered well-suited for successful completion.
How does this study align with NIH priorities?
The study addresses NIH priorities by leveraging real-world data (All of Us) for chronic disease research (diabetes), employing a replicable and methodologically rigorous approach, focusing on clearly measurable health outcomes (new-onset diabetes), training the future biomedical workforce, and contributing to solution-oriented approaches to improving population health.
What are some potential impacts or applications of this study's findings?
Findings will identify populations at risk for new-onset diabetes post-COVID-19. This can guide the development of targeted interventions, enable earlier detection and prevention strategies, and optimize public health approaches to address the broader burden of chronic diseases.
What is the source authority level of this research project information?
The source metadata for this article indicates a 'Very High' source authority level (90 priority score) and confirms it's from the National Institute of Nursing Research.